Mykor, a biotech firm turning industrial and agricultural waste into low-carbon construction products has raised £4m in new funding.
The Bristol-based firm said it will use the new funds to accelerate the scaling up of its industrial biofabrication technologies.
Its technology works by combining engineered mycelium strains, green chemistry additives and closed-loop automated manufacturing processes to produce products such as prefab walls and insulation.
“We’ve built Mykor around the idea that decarbonising construction cannot come at the expense of cost, performance or practicality,” said co-founder and chief executive Olivia Page.
“The challenge has never just been inventing a biomaterial — it’s been manufacturing these systems at industrial scale and integrating them into real construction supply chains. This funding allows us to scale that model further alongside major contractors and manufacturing partners globally.”
The new investment came from Clean Growth Fund as well as the South West Investment Fund from British Business Bank and Innovate UK.
“Mykor addresses one of construction’s most pressing challenges: reducing embodied carbon without adding cost or complexity,” said Susannah McClintock, investment partner at Clean Growth Fund.
“Their solution integrates seamlessly into existing building practices and is cost-competitive with conventional materials — delivering meaningful carbon savings without adding cost.”
